Peptide library / 5-Amino-1MQ

5-Amino-1MQ

5-Amino-1MQ is an experimental small-molecule inhibitor of nicotinamide N-methyltransferase; it is not a peptide.

Peptide & blend guide

The short version

Why people discuss it
Discussed for fat loss, body composition and metabolic goals linked to NNMT inhibition. Community interest does not establish benefit or a suitable treatment.
What it is
5-Amino-1MQ is an experimental small-molecule inhibitor of nicotinamide N-methyltransferase; it is not a peptide.
Biggest caution
Cell and animal metabolic findings do not establish human weight-loss benefit, dosing or safety. Commercial naming does not verify chemical identity, purity or pharmacology.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Source agreement describes reported practice, not clinical validation.

Oral

Community reference · Not clinical guidance
Amount
50–100 mg
Frequency
Once daily
Duration / phase
Reported example: 4–6 weeks on, 2–4 weeks off

Legacy oral community/model-derived pattern. The newer 2.5–5 mg injected schedule describes a different route and does not validate oral dose equivalence. Reference only; this does not establish safety, effectiveness or individual suitability.

Reference source · reviewed 2026-09-12
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library